Credit Suisse’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$3.43M Buy
66,010
+127
+0.2% +$5.57K ﹤0.01% 1516
2023
Q4
$2.35M Buy
65,883
+2,489
+4% +$86.7K ﹤0.01% 1787
2023
Q3
$2.12M Sell
63,394
-4,940
-7% -$171K ﹤0.01% 1803
2023
Q2
$2.57M Buy
68,334
+15,228
+29% +$501K ﹤0.01% 1752
2023
Q1
$1.56M Sell
53,106
-5,823
-10% -$169K ﹤0.01% 2025
2022
Q4
$1.55M Buy
58,929
+6,398
+12% +$152K ﹤0.01% 2032
2022
Q3
$1.22M Buy
52,531
+4,227
+9% +$115K ﹤0.01% 2189
2022
Q2
$1.22M Sell
48,304
-591
-1% -$17.5K ﹤0.01% 2249
2022
Q1
$1.87M Buy
48,895
+2,039
+4% +$73.6K ﹤0.01% 2131
2021
Q4
$1.84M Sell
46,856
-574
-1% -$25.2K ﹤0.01% 2854
2021
Q3
$2.31M Sell
47,430
-3,013
-6% -$156K ﹤0.01% 2715
2021
Q2
$2.65M Buy
50,443
+4,962
+11% +$283K ﹤0.01% 2625
2021
Q1
$2.53M Sell
45,481
-37,627
-45% -$1.7M ﹤0.01% 2639
2020
Q4
$2.57M Buy
83,108
+7,018
+9% +$167K ﹤0.01% 2635
2020
Q3
$1.41M Sell
76,090
-58,779
-44% -$973K ﹤0.01% 2688
2020
Q2
$1.86M Buy
134,869
+84,207
+166% +$1.14M ﹤0.01% 2438
2020
Q1
$464K Sell
50,662
-47,029
-48% -$705K ﹤0.01% 3163
2019
Q4
$1.7M Buy
97,691
+39,629
+68% +$675K ﹤0.01% 2744
2019
Q3
$879K Buy
58,062
+9,684
+20% +$169K ﹤0.01% 3091
2019
Q2
$914K Buy
48,378
+24,076
+99% +$411K ﹤0.01% 3001
2019
Q1
$426K Buy
24,302
+1,045
+4% +$19.1K ﹤0.01% 3423
2018
Q4
$405K Buy
+23,257
New +$348K ﹤0.01% 3370
2018
Q3
Sell
-12,365
Closed -$120K 3995
2018
Q2
$120K Buy
+12,365
New +$154K ﹤0.01% 3819
2013
Q3
Sell
-3,440
Closed -$28K 4378
2013
Q2
$28K Buy
+3,440
New +$41.4K ﹤0.01% 4133

Other funds holding VCEL

Credit Suisse's VCEL Position: Q1 2024 in Review

Credit Suisse increased its Vericel Corp (VCEL) stake by 0.19% in Q1 2024, buying an estimated $5.57K and bringing the position to 66,010 shares worth $3.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1516.

Credit Suisse first reported a position in VCEL in Q2 2013 and has held it in 24 quarters since. 257 funds tracked by Wall St. Rank hold VCEL as of Q1 2024.

  • Credit Suisse held 66,010 shares of Vericel Corp worth $3.43M as of Q1 2024.
  • Credit Suisse bought 127 Vericel Corp shares in Q1 2024, an estimated $5.57K.
  • Vericel Corp made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1516 holding.
  • Credit Suisse first reported a position in Vericel Corp in Q2 2013 and has held it in 24 quarters since.
  • 257 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.